Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results (Q35849776)

From Wikidata
Jump to navigation Jump to search
scientific article published on 7 March 2006
edit
Language Label Description Also known as
English
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results
scientific article published on 7 March 2006

    Statements

    Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results (English)
    Timothy Hughes
    Michael Deininger
    Jaspal Kaeda
    Nicholas C P Cross
    Jean Gabert
    David Grimwade
    Jeffrey H Lipton
    Janina Longtine
    Wendy Stock
    John M Goldman
    7 March 2006
    108
    28-37

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit